Selenium Exerts Antimicrobial Activity against the Perinatal Pathogen Streptococcus agalactiae and Perturbs Bacterial

Riya Chinni1, Kensley Horner2, Walter Avila2

  • 1Medicine Health and Society, Vanderbilt University, Nashville, Tennessee 37232, United States.

ACS Bio & Med Chem Au
|October 20, 2025
PubMed

Insights

Selenium shows antimicrobial activity against Group B Streptococcus (GBS), inhibiting its growth and adherence. This suggests selenium could be a cost-effective method to reduce GBS perinatal infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Nutritional Science

Background:

  • Group B Streptococcus (GBS) is a pathogenic bacterium causing severe perinatal infections.
  • Epidemiological data suggest selenium offers protection against infections and supports healthy pregnancy.
  • The potential antimicrobial role of selenium against GBS remains unexplored.

Purpose of the Study:

  • To investigate the antimicrobial activity of selenium against GBS.
  • To evaluate selenium's effect on GBS growth and adherence to gestational tissues.
  • To compare the sensitivity of colonizing and invasive GBS strains to selenium.

Main Methods:

  • Exposure of GBS strains (colonizing and invasive) to varying concentrations of selenium.
  • Assessment of bacterial growth inhibition in response to selenium.
  • Evaluation of GBS adherence to gestational tissues following selenium exposure.

Main Results:

  • Selenium demonstrated significant inhibition of GBS growth.
  • Selenium reduced GBS adherence to gestational tissues.
  • Colonizing GBS strains were more sensitive to selenium's inhibitory effects than invasive strains.

Conclusions:

  • Selenium exhibits antimicrobial properties against GBS.
  • Selenium can inhibit GBS growth and reduce its adherence to maternal tissues.
  • Selenium presents a potential cost-effective intervention for preventing GBS-related perinatal infections.

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
2.6K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K